VEXT — Vext Science Income Statement
0.000.00%
Last trade - 00:00
- CA$52.19m
- CA$101.89m
- $35.41m
- 76
- 92
- 62
- 91
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 18.5 | 22.3 | 25.2 | 37.2 | 35.4 |
Cost of Revenue | |||||
Gross Profit | 9.17 | 9.47 | 10 | 16.5 | 20.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 12.9 | 18.7 | 22.6 | 30.3 | 26.3 |
Operating Profit | 5.57 | 3.62 | 2.61 | 6.98 | 9.08 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4.88 | 3.67 | 2.64 | 6.82 | 6.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.75 | 2.79 | 2.13 | 4.99 | 10.9 |
Net Income Before Extraordinary Items | |||||
Net Income | 3.75 | 2.79 | 2.13 | 4.99 | 10.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.75 | 2.79 | 2.13 | 4.99 | 10.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.201 | 0.123 | 0.048 | 0.034 | 0.069 |